~/ Tissue samples from 20 patients with various intracraniat tumors and one case of cerebral contusion were analyzed for the cytosolic glucocorticoid-receptor concentration using isoelectric focusing in slabs of polyacrylamide gel. It is pointed out that the clinical response to dexamethasone in brain edema associated with various intracranial lesions is, to some extent, parallel to the glucocorticoid-receptor concentration in these tumors. The findings in this investigation suggest that the cytosolic gtucocorticoid receptor might be responsible for the initiation of a series of biochemical effects of steroids affecting brain edema. It is possible that the first step in eliciting a beneficial clinical response to dexamethasone in patients with brain tumors is the formation of a steroid-receptor complex in the peripheral parts of the tumor.
G
LUCOCORTICOID steroids are widely used in the treatment of various kinds of brain edema. The effect of glucocorticoid steroids on brain edema related to intracranial tumors, cerebral infarctions, and head injuries has been extensively studied, 2-5,9-n'17 but many aspects of brain edema have not been clarified. Furthermore, the actual mechanism of the effect of the glucocorticoid on brain edema is still unknown. In recent years, many investigations have shown that the glucocorticoid hormones are similar to other steroid hormones and bind to specific receptors in target cells. The formation of the steroid-receptor complex is the first step in a series of events that lead to the biological effects induced by these hormones. 1,7 A detailed knowledge of the structure and function of the glucocorticoid receptor is essential for an understanding of the mechanism of action of steroid hormones on brain edema.
Glucoconicoid receptors have been studied in rat brain and are well characterized, s,~4,a5 In a recent report, glucocorticoid receptors were investigated in autopsy material from human brains, x3 We have compared the characteristics of the glucocorticoid receptor in human brain cytosol using specimens obtained during surgery with those of the glucocorticoid receptor of the rat brain, is No difference in chemical characteristics between these receptors was noted. We report on the concentration of cytosoiic glucocorticoid receptors in 20 cases of intracranial tumors and in one case of brain contusion. The purpose of this study was to investigate the possible existence of a relationship between the cytosolic glucocorticoid-receptor concentrations in various tumors and the clinical effects of steroid hormones on brain edema.
Materials and Methods
Tissue samples were obtained from 21 patients (11 males and 10 females) subjected to surgery for intracranial lesions. The patients ranged in age from 13 to 69 years. There were six meningiomas, five acoustic neuromas, six gliomas, one chordoma, two intracranial metastases, and one case of cerebral contusion. In 10 cases, peritumoral brain tissue was removed during surgery and was also used for the measurement of receptor concentrations. In one of the metastatic tumors, the receptor concentrations were measured in the central and peripheral parts of the tumor as well as in the peritumoral brain tissue on two separate i-This patient had been subjected to surgery twice; the interval between the two operations was 9 months. 
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occasions. In all these patients, glucocorticoid steroid treatment was withheld before and during surgery.
Samples weighing at least 0.3 gm were immediately stored at -70~ and analyzed within 10 days. The samples were homogenized, and cytosol prepared as described previously. 15,1s Glucocorticoid receptors were labeled in vitro by incubating the cytosol for 2 hours at 0~ in the presence of 1 • 10-7M [3H]-dexamethasone. Parallel incubations containing an excess (100-fold) of unlabeled dexamethasone were also carried out. The cytosolic glucocorticoid-receptor concentration was measured using isoelectric focusing in slabs of polyacrylamide gel after limited trypsin digestion and treatment with dextran-coated charcoal. This technique has previously been demonstrated to be a convenient method for characterization and measurement of the glucocorticoid receptor in the rat hippocampus 15 and human brain, is After isoelectric focusing and scintillation counting, the results were calculated as the total cytosolic, glucocorticoid binding minus the nonspecific binding and were expressed in femtomoles per mg (fmol/mg) of cytosolic protein. The cytosolic protein was measured according to the method of Lowry, et al., 6 using bovine serum albumin as standard.
Results
The highest values of receptor concentrations were noted in one of two metastatic tumors (279 fmol/mg), and the lowest value was found in the case of cerebral contusion (1.4 fmol/mg, Table 1 ).
In six meningiomas, the concentration of the glucocorticoid receptor ranged from 122 to 220 fmol/mg (mean 171 fmol/mg protein). The levels of the receptor in five acoustic neuromas were lower than those of the meningiomas, with a range of 78 to 117 fmol/ mg and a mean of 99 fmol/mg. The group of six gliomas contained lower concentrations of receptor than the group of acoustic neuromas. The range of the receptor values in the gliomas was 13 to 117 fmol/ mg (mean 60 fmol/mg).
In peritumoral cerebral and cerebellar tissues, the receptor concentrations ranged from 2.3 to 59 fmol/ mg and from 50 to 82 fmol/mg with means of 32 fmol/mg and 67 fmol/mg, respectively ( Table 2 ). The receptor concentrations measured in the central and peripheral parts of the metastatic brain tumor (hypernephroma) were 95 fmol/mg and 142 fmol/mg, respectively, on the first occasion and 62 fmol/mg and 153 fmol/mg, respectively, on the second. The levels of receptor concentrations in the surrounding brain tissue were 30 fmol/mg and 54 fmol/mg on the first and second occasions, respectively (Fig. 1) .
Discussion
In the present series of tumors, metastatic cancers and meningiomas were found to contain the highest glucocorticoid receptor concentrations. The five acoustic neuromas had intermediate values, whereas most of the gliomas had fairly low values. These results suggest that the glucocorticoid receptor concentration of a tumor is determined by its histological type. On the other hand, the degree of histological or biological malignancy does not seem to be an important determinant of the glucocorticoid receptor concentration. The gliomas had different grades of malignancy without a systematic relation between grade and receptor content. Two of the meningiomas were atypical and malignant, but their receptor concentrations still fell within the boundaries listed for the whole meningioma group.
Glucocorticoid receptors in brain tumors
The results of the present investigation may be compared to the clinical response to dexamethasone in cases of brain edema associated with various cerebral diseases, as reported by Reulen, et aL 11 The comparison demonstrates that conditions which respond well to dexamethasone are also characterized by high levels of glucocorticoid receptors, whereas conditions known to respond less favorably are characterized by low levels of glucocorticoid receptors (Fig. 2) . The ranking order in the two lists compares fairly well except for the meningiomas. The reason for this exception is not known.
A previously published report on the glucocorticoid receptor content of brain tissue in autopsy material 13 did not describe obvious differences between cerebral and cerebellar tissue. The analysis of the receptor content of peritumoral brain tissue in our series showed, however, a definite difference between values from cerebellar and cerebral tissue. It seems reasonable to assume that the low values obtained from cerebral brain tissue are due to the fact that these samples were obtained from the immediate vicinity of infdtrating tumors, whereas the samples of cerebellar tissue were taken from regions separated from the pontine angle tumor by the subarachnoid space. The fact that the damaged brain tissue is characterized by a low glucocorticoid receptor value is further substantiated by the very low receptor concentration in traumaticaUy damaged tissue.
It is interesting to compare the present results with those reported by Yamada, et al., TM who investigated the concentration of intravenously administered [3H]-dexamethasone in a choriocarcinoma experimentally implanted into a monkey brain. The concentration of [3H]-dexamethasone was found to be higher at the periphery of the brain tumor than in the central part. This distribution is similar to the one demonstrated for the glucocorticoid receptor (Fig. 1) . This also agrees with findings by Silfversw~ird, et al., 12 who reported that central parts of mammary carcinomas have lower estrogen-receptor concentrations than peripheral parts. Yamada, et al., TM however, found high concentrations of radioactive dexamethasone not only at the periphery of the tumor, but also in adjacent cortex and white matter. They could show that sites with high concentrations of dexamethasone also showed significant improvement of brain edema after dexamethasone treatment, suggesting that dexamethasone might act directly at these loci. In contrast, the present study shows that the content of glucocorticoid receptors in most instances is low in tissue adjacent to the tumor. Yamada, et al., ~6 may have observed a nonspecific leakage of labeled dexamethasone into the tissue surrounding the tumor. It is possible that the first step in eliciting a beneficial clinical response to steroids in patients with brain tumors is the formation of a steroid-receptor complex in the peripheral parts of the tumor, where receptor protein frequently is available in large quantities.
The t'mdings of this investigation, taken in conjunction with clinical experience 11 and the experimental results of Yamada, et al., TM suggest that the cytosolic glucocorticoid-receptor complex may be responsible for the initiation of a series of biochemical actions of steroids on brain edema.
